HERAN HealthTech Fund II

About HERAN HealthTech Fund II

Antwerp-based HERAN Partners closed €90M for its second healthtech fund. Anchored by €20M from EIF and €10M from PMV. Fund I delivered >30% IRR with exits including icometrix (acquired by GE HealthCare).

Investment Focus

Location / RegionBelgium

Funding StageSeed

Industry Focus

Ai Ml

Biotech

Digital Health

Med Tech

Investor Signals Profile

active

Sweet Spot

Bold HealthTech/LifeSci founder with solid tech platform

HealthTech

Life Sciences

Drug Discovery

Women's Health

Diagnostics

Microfluidics

Biologics

Bullish Signals

Fund II: 2 deals already closedexternal

Led €6M round for Pharmaceleraexternal

Belgium-based, invests UK/ES/BEexternal

Active investor with network & mentorshipexternal

2026: Fluidic Sciences (UK) addedwebsite

Portfolio spans UK, ES, BEwebsite

Hypervision Surgical: £17M Series Awebsite

3 portfolio co's: drug discovery + AI + microfluidicswebsite

Gynaia (BE): AI-powered gynecology diagnosticswebsite

Pharmacelera: 75,000x faster drug designwebsite

Team: scientific + entrepreneurial backgroundswebsite

Contrarian Signals

Healthcare-only — narrow vertical focusexternal

Small team, limited public GP infoexternal

No named GPs visible publiclywebsite

Founder Do's

Show transformative impact potential

Have strong scientific background

Build scalable technology platform

Demonstrate perseverance & drive

Target life sciences / healthcare disruption

Founder Don'ts

No clear science or tech platform

Avoid non-healthcare verticals

Lack market scalability evidence

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€90M

Saves0

Website

Key People

Geert Cromheecke